The information in this website is intended only for healthcare professionals. By entering this site, you are confirming that you are a healthcare professional.
The information in this website is intended only for laboratory professionals. By entering this site, you are confirming that you are a laboratory professional.
The Phadia Immunology Reference Laboratory (PiRL) offers a menu of cutting-edge assays to help extend your efforts beyond the current boundaries of innovative diagnostic testing technology. In addition, PiRL, a CLIA-certified laboratory, evaluates new, state-of-the-art analytes prior to full commercial launch in the US.
As pioneers in allergy and autoimmune disease diagnostics, we strive to provide innovative assays and component technology not available elsewhere.
PiRL provides a menu of options from trusted allergy and autoimmune disease diagnostics to innovative molecular testing including:
We offer customized reports and timely service to our customers as well as added value, by providing clinical expertise and world-class diagnostic assays.
Step 1: Complete the Customer Account Initiation Form
Step 2: Within 2 weeks of the form being received and processed, your customer starter kit will be sent.
Step 3: Select the appropriate tests - refer to the Product Catalog for a listing of the assays available
Step 4: Complete all forms - download, print, and fill out the Testing Requisition Form (or fill out the requisition form provided in the starter kit) and submit one form for each patient sample shipped.
Step 5: Package and ship the specimen– refer to Sample Processing for packaging and shipping details.
Our goal is to support investigators with diagnostic tests and testing services to advance the understanding of the clinical utility and health economic benefits of testing across numerous disease states.
Areas of interest include:
Come Partner with Us
Availability, turnaround times and sample shipping instructions may vary by test.
HIPAA: PiRL is committed to compliance with HIPAA and its regulations. All protected health information (PHI) provided to PiRL shall be treated as confidential. Under federal law, Thermo Fisher Scientific may release lab results only to the ordering physician or other healthcare provider responsible for the patient's care, and not to third parties, including the patient.